The nurse is caring for a client who has a finger stick blood glucose level of 130 mg/dL (7.21 mmol/L) Prior to administering the scheduled dose of acarbose, the nurse is informed that morning meal trays will be 30 minutes late. Which action should the nurse take?
Reference Range:
Glucose [74 to 106 mg/dl. (4.1 to 5.9 mmol/L)]
Administer the medication
Notify the healthcare provider.
Hold the medication until the meal trays arrive.
Obtain another finger tick blood glucose level.
The Correct Answer is C
A. Administer the medication: Acarbose is an alpha-glucosidase inhibitor that should be taken with the first bite of a meal to effectively manage postprandial blood glucose levels. Administering it before the meal is inappropriate as it can lead to inadequate glucose control.
B. Notify the healthcare provider: While notifying the healthcare provider might be necessary if there are significant issues, it is not the immediate action needed in this situation. The priority is to manage the timing of the medication relative to the meal.
C. Hold the medication until the meal trays arrive: Acarbose should be taken with food to work effectively in controlling blood glucose levels after meals. If the meal is delayed, the medication should be held until the meal is ready to ensure proper administration.
D. Obtain another finger stick blood glucose level: Rechecking the blood glucose level does not address the issue of the timing of the acarbose administration. The focus should be on ensuring the medication is taken with the meal.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Instruct the client that since the hematocrit remains low, the daily injections are still necessary: A hematocrit of 43% is within the normal range, suggesting the client’s anemia is improving. If the hematocrit were still low, continuing daily injections would be appropriate, but this is not the case here.
B. Notify the healthcare provider of the client’s hematocrit level so the frequency of injections can be reduced: Since the hematocrit is normal, there is no need to notify the healthcare provider specifically for changing the injection frequency based solely on the hematocrit level. Reducing injection frequency should be based on the overall treatment plan and not just the current hematocrit.
C. Advise the client that the medication is having the desired effect, but daily injections will continue to be needed for life for this chronic condition: While the medication may be effective, informing the client about the potential for less frequent injections could improve adherence and reduce discomfort, if the healthcare provider approves.
D. Offer to instruct the client in self-administration techniques to improve the client's sense of control over the painful daily injections: Teaching self-administration can empower the client and potentially reduce discomfort by allowing the client to become more comfortable with the process. It also offers the opportunity for the client to manage their injections more conveniently and with greater control.
Correct Answer is B
Explanation
Simvastatin is a medication used to lower cholesterol and reduce the risk of cardiovascular events, such as heart attacks. It is most commonly prescribed to individuals with a history of heart disease, high cholesterol, or related conditions like angina. The other options are less likely to benefit from simvastatin based on the information provided.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
